Certain genes boost fish oils' protection against breast cancer

September 21, 2004

LOS ANGELES (Sept. 21, 2004) - Researchers who found that fish oils appear to reduce breast cancer risk have now discovered that the oils may especially benefit women with particular genetic makeups.

The protective effects of fish oils, called marine n-3 or omega-3 fatty acids, are linked to the cancer-fighting properties of the oil's byproducts, propose investigators from the Keck School of Medicine of the University of Southern California and the National University of Singapore. The study in Carcinogenesis was published early online through the journal's Web site.

Moreover, researchers believe that women whose bodies do a poor job of getting rid of the fish oils' byproducts are the ones who benefit most from consuming the oils. That may help scientists better understand exactly how fish oils deter cancer.

"In this study, we found that women with certain common DNA patterns experienced more breast cancer protection from marine n-3 fatty acids than women with other common patterns," explained Manuela Gago-Dominguez, M.D., Ph.D., assistant professor of preventive medicine at the Keck School of Medicine of USC and the study's lead author.

Findings came from the Singapore Chinese Health Study, a prospective investigation of diet and cancer risk in more than 63,000 Chinese men and women in Singapore.

"Through this study, we have identified a novel gene-environmental interaction between certain genotypes and omega-3 fatty acids on breast cancer development," says Mimi C. Yu, Ph.D., professor of preventive medicine at the Keck School and principal investigator of the Singapore Chinese Health Study.

The researchers had already found that among postmenopausal women in this group, those who ate the most n-3 fatty acids (from fish such as salmon and mackerel) were 34 percent less likely to be diagnosed with breast cancer than women who ate the least n-3 fatty acids from fish. They suspected that lipid peroxidation products-that is, substances produced when the fatty acids break down-were behind the protection.

Gago-Dominguez explains that certain enzymes in the body known as glutathione S-transferases (GSTs, for short) help the body flush out and get rid of these lipid peroxidation products. Each person has certain genes that carry the recipe for making GST. But interestingly, these genes can be found in slightly different varieties-called polymorphisms-in the population. The differences between the genes can mean the difference between GST that clears substances efficiently out of the body and GST that works a little slower.

The researchers looked at the genetic makeup of study participants and grouped them according to which polymorphisms they had. They found that postmenopausal women who had low-activity versions of genes associated with GSTs (known as GSTM1, GSTT1 and GSTP1) had a lower risk of breast cancer. Women with a combination of the lowest-activity forms of GSTM1 and GSTP1 had 64 percent lower risk of the cancer, and women with a combination of the lowest-activity forms of GSTT1 and GSTP1 had a 74 percent lower risk of the cancer.

Among women with high-activity versions of GST-related genes, though, they saw no evidence that fish oils reduced breast cancer risk. That held true for both pre- and postmenopausal women.

Interestingly, laboratory studies have shown that cancer growth is suppressed by n-3 fatty acid byproducts, and the suppression is enhanced by drugs that increase lipid peroxidation. When antioxidants are introduce to battle the effects of peroxidation, though, the cancer continues to grow.

"Our findings may have practical implications in treatment and prevention strategies for breast cancer," says Gago-Dominguez. "Marine n-3 fatty acids have been shown to enhance the cancer-killing effect of certain chemotherapy drugs and radiotherapy in experimental studies. Since these anti-cancer agents may act, at least in part, through similar oxidative mechanisms as n-3 fatty acids-which is why patients under chemotherapy are advised not to take antioxidant vitamin supplements-understanding the anti-cancer effect of marine n-3 fatty acids may be important to finding the mechanisms for killing cancer cells."
-end-
Manuela Gago-Dominguez, J. Esteban Castelao, Can-Lan Sun, David Van Den Berg, Woon-Puay Koh, Hin-Peng Lee, and Mimi C. Yu, "Marine n-3 fatty acid intake, glutathione S-transferase polymorphisms and breast cancer risk in postmenopausal Chinese women in Singapore. Carcinogenesis, published early online; doi:10.1093/carcin/bgh230.

University of Southern California

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.